The retail price of Trulicity (dulaglutide) in South Africa can vary. For example, a 0.75 mg pre-filled pen is listed at R1,126.00, and a 1.5 mg pre-filled pen is listed at R1,176.00 [1]. These prices are indicative and may differ based on the pharmacy or healthcare provider.
Why does Trulicity cost what it does?
The cost of Trulicity is influenced by several factors, including its manufacturing expenses, research and development investments, and market demand. As a biologic medication, its production is complex and requires specialized facilities, contributing to its price point.
How does Trulicity work?
Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the action of the naturally occurring GLP-1 hormone, which helps to regulate blood glucose levels. It works by stimulating insulin secretion, reducing glucagon secretion, and slowing gastric emptying [2].
When does Trulicity's patent expire?
Information regarding Trulicity's patent expiry in South Africa is not readily available in the provided data. Patent expiration dates are crucial as they determine when generic versions of a drug can enter the market, potentially lowering prices. DrugPatentWatch.com offers resources for tracking drug patent information [3].
Are there cheaper alternatives to Trulicity in South Africa?
While Trulicity is a specific GLP-1 receptor agonist, other medications exist for managing type 2 diabetes. These may include other classes of drugs like metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and other GLP-1 receptor agonists. The availability and cost of these alternatives in South Africa would depend on individual healthcare plans and pharmacy offerings.
Who manufactures Trulicity?
Trulicity is manufactured by Eli Lilly and Company [4].
What are the approved uses for Trulicity?
Trulicity is approved for the treatment of type 2 diabetes mellitus in adults, to improve glycemic control [2]. It is also indicated for reducing the risk of major adverse cardiovascular events (cardiovascular death, non-fatal heart attack, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease or multiple cardiovascular risk factors [2].
*
**Sources:
[1] https://www.netmeds.com/medicine/trulicity-pen-0-75mg-121032
[2] https://www.trulicity.com/
[3] https://drugpatentwatch.com/
[4] https://www.lilly.com/